drugset / Trial / NCT02733835

VPIA Remifentanil for Labour Pain to Reduce Maternal Desaturation and Improve Analgesic Titration

NCT02733835

Phase 4 Unknown 25 enrolled KK Women's and Children's Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study is a prospective cohort study aiming to evaluate an improved VPIA remifentanil algorithm which would benefit labouring mothers who are unable or unwilling to receive epidural analgesia

Timeline

Start
2016-12
Primary completion
2017-12
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule Intravenous

Indications

No indication recorded.